Laborie Medical Technologies Welcomes Chris Smith as New CEO to Drive Future Growth Laborie Medical Technologies has appointed Chris Smith as its new CEO, effective September 22, 2025, succeeding Michael Frazzette. Smith, an experienced leader in medtech, aims to drive innovation and growth.

Laborie Medical Technologies Welcomes Chris Smith as New CEO to Drive Future Growth #USA #Healthcare_Leadership #Portsmouth #Chris_Smith #Laborie_Medical

Laborie's Optilume® Drug-Coated Balloon Secures New Coverage from BCBSM for Patients Laborie Medical Technologies' Optilume® Drug-Coated Balloon has received extended coverage from Blue Cross Blue Shield of Michigan, enhancing treatment options for patients.

Laborie's Optilume® Drug-Coated Balloon Secures New Coverage from BCBSM for Patients #United_States #Portsmouth #Optilume #Laborie_Medical #BCBSM

Revolutionary Study Validates Durability of Optilume® Drug-Coated Balloon for Urethral Treatment A recent study confirms the long-term effectiveness of the Optilume® Drug-Coated Balloon in treating recurrent urethral strictures, showcasing significant patient outcomes over three years.

Revolutionary Study Validates Durability of Optilume® Drug-Coated Balloon for Urethral Treatment #USA #Optilume #Portsmouth,_New_Hampshire #Laborie_Medical #Urethral_Strictures